0NZN Stock Overview
Produces and sells perfumes, aromas, and natural products. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 0NZN from our risk checks.
Robertet SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €868.00 |
52 Week High | €974.00 |
52 Week Low | €754.00 |
Beta | 0.33 |
11 Month Change | -10.05% |
3 Month Change | 1.40% |
1 Year Change | 12.14% |
33 Year Change | -11.79% |
5 Year Change | -9.93% |
Change since IPO | 171.27% |
Recent News & Updates
Recent updates
Shareholder Returns
0NZN | GB Chemicals | GB Market | |
---|---|---|---|
7D | -10.1% | -5.0% | -0.3% |
1Y | 12.1% | -18.5% | 6.1% |
Return vs Industry: 0NZN exceeded the UK Chemicals industry which returned -18.2% over the past year.
Return vs Market: 0NZN exceeded the UK Market which returned 5.6% over the past year.
Price Volatility
0NZN volatility | |
---|---|
0NZN Average Weekly Movement | 3.3% |
Chemicals Industry Average Movement | 5.5% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0NZN has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0NZN's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1850 | 2,153 | Jerome Bruhat | www.robertet.com |
Robertet SA produces and sells perfumes, aromas, and natural products. The company operates in four segments: Raw materials, Fragrances, Flavors, and Active Ingredients. It also produces organic essential oils and active ingredients.
Robertet SA Fundamentals Summary
0NZN fundamental statistics | |
---|---|
Market cap | €1.81b |
Earnings (TTM) | €86.35m |
Revenue (TTM) | €759.29m |
21.0x
P/E Ratio2.4x
P/S RatioIs 0NZN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0NZN income statement (TTM) | |
---|---|
Revenue | €759.29m |
Cost of Revenue | €336.45m |
Gross Profit | €422.84m |
Other Expenses | €336.49m |
Earnings | €86.35m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 41.34 |
Gross Margin | 55.69% |
Net Profit Margin | 11.37% |
Debt/Equity Ratio | 61.8% |
How did 0NZN perform over the long term?
See historical performance and comparison